- Home
- RAPT vs EML Comparison
RAPT vs EML Comparison
Compare RAPT & EML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- EML
- Stock Information
- Founded
- RAPT 2015
- EML 1858
- Country
- RAPT United States
- EML United States
- Employees
- RAPT N/A
- EML N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- EML Industrial Machinery/Components
- Sector
- RAPT Health Care
- EML Consumer Discretionary
- Exchange
- RAPT Nasdaq
- EML Nasdaq
- Market Cap
- RAPT 117.5M
- EML 134.7M
- IPO Year
- RAPT 2019
- EML N/A
- Fundamental
- Price
- RAPT $7.35
- EML $23.11
- Analyst Decision
- RAPT Buy
- EML
- Analyst Count
- RAPT 5
- EML 0
- Target Price
- RAPT $42.00
- EML N/A
- AVG Volume (30 Days)
- RAPT 120.8K
- EML 8.4K
- Earning Date
- RAPT 08-07-2025
- EML 08-05-2025
- Dividend Yield
- RAPT N/A
- EML 1.90%
- EPS Growth
- RAPT N/A
- EML N/A
- EPS
- RAPT N/A
- EML N/A
- Revenue
- RAPT N/A
- EML $271,440,503.00
- Revenue This Year
- RAPT N/A
- EML $1.56
- Revenue Next Year
- RAPT N/A
- EML $7.00
- P/E Ratio
- RAPT N/A
- EML $11.01
- Revenue Growth
- RAPT N/A
- EML 8.15
- 52 Week Low
- RAPT $5.67
- EML $19.06
- 52 Week High
- RAPT $30.60
- EML $35.03
- Technical
- Relative Strength Index (RSI)
- RAPT 43.57
- EML 50.64
- Support Level
- RAPT $6.88
- EML $22.28
- Resistance Level
- RAPT $8.91
- EML $23.77
- Average True Range (ATR)
- RAPT 0.70
- EML 0.53
- MACD
- RAPT -0.16
- EML 0.01
- Stochastic Oscillator
- RAPT 11.36
- EML 64.71
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.